Open AccessCHEMICALLY MODIFIED TETRACYCLINE (CMT) DECREASES NEUTROPHIL PROTEASE ACTIVITY AND PREVENTS POST-PUMP SYNDROME (PPS).
Author(s) -
Gary F. Nieman,
Charles J. Lutz,
Darrell H. Carney,
Anthony Picone,
Louis A. Gatto,
N. S. Ramamurthy,
Lorne M. Golub,
B Seaiics,
Kathy Snyder,
Andrew M. Paskanik,
Christine Finck
Publication year - 1998
Publication title -
shock
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.095
H-Index - 117
eISSN - 1540-0514
pISSN - 1073-2322
DOI - 10.1097/00024382-199806001-00109
Subject(s) - tetracycline , protease , chemistry , protease inhibitor (pharmacology) , microbiology and biotechnology , medicine , biology , biochemistry , enzyme , virology , antibiotics , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load